Status | Study |
Suspended |
Study Name: Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer Condition: Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Date: 2010-12-23 Interventions: Biological: Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001 |
Completed |
Study Name: Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2009-11-10 Interventions: Other: Diagnostic Laboratory Biomarker Analysis |
Completed |
Study Name: Ixabepilone to Treat Cervical Cancer Condition: Cervical Carcinoma Cervical Adenocarcinoma Cervical Date: 2009-06-17 Interventions: Drug: Ixempra (Ixabepilone (BMS-247550) ) Participants received Ixabepilone 6mg/m^2 for a total of 30mg/ |
Terminated |
Study Name: Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial) Condition: Cervical Cancer Squamous Cell Carcinoma Date: 2009-05-06 Interventions: Procedure: CT Abdomen and Pelvis scan + whole body PET-CT scan |
Completed |
Study Name: Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2009-01-09 Interventions: Drug: Gemcitabine Hydrochloride Given IV Other Names |
Completed |
Study Name: Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Condition: Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Date: 2008-12-04 Interventions: Biological: Bevacizumab Given |
Terminated |
Study Name: Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer Condition: Carcinoma, Large Cell Carcinoma, Non-Small-Cell Lung Carci Date: 2008-05-05 Interventions: Drug: CP 751,871 (Figitumumab) |
Terminated |
Study Name: Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology Condition: Carcinoma, Squamous Cell Carcinoma, Adenosquamous Date: 2008-01-03 Interventions: Drug: CP-751,871 (Figitumumab) |
Completed |
Study Name: Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck Condition: Squamous Cell Carcinoma of the Head and Neck Basaloid Squamous Cell Carcinoma Date: 2007-12-10 Interventions: Drug: Abraxane Other Name: pac |
Completed |
Study Name: Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery Condition: Cervical Adenocarcinoma Cervical Adenosquamous Cell Carcinoma Date: 2006-10-18 Interventions: Drug: sunitinib malate Given PO Other Names: |